World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 8 February 2016
Main ID:  NCT02668965
Date of registration: 27/01/2016
Prospective Registration: No
Primary sponsor: Mahidol University
Public title: The Effects of Intrauterine Infusion of hCG at the Time of Embryo Transfer
Scientific title: The Effects of Intrauterine Infusion of Human Chorionic Gonadotropin at the Time of Embryo Transfer on IVF/ICSI Outcomes: Randomized, Double-blind Controlled Study
Date of first enrolment: December 2015
Target sample size: 200
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT02668965
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Health Services Research  
Phase:  N/A
Countries of recruitment
Thailand
Contacts
Name:     savinee boonsuk, M.D.
Address: 
Telephone: +66818706643
Email: noomnim_mu@hotmail.com
Affiliation: 
Name:     savinee boonsuk, M.D.
Address: 
Telephone: +66818706643
Email: noomnim_mu@hotmail.com
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

1. infertile women aged 18-43 years

2. indicated or willing for IVF/ICSI treatment or endometrial preparation for embryo
transfer

Exclusion Criteria:

1. Azoospermic male partner

2. Failure to retrieve oocyte after controlled ovarian hyperstimulation

3. No embryo retrieved for transfer

4. Endometrial preparation failure



Age minimum: 18 Years
Age maximum: 43 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Infertility
Intervention(s)
Procedure: Intrauterine hCG (pregnyl)
Primary Outcome(s)
Clinical pregnancy rate [Time Frame: 2 weeks after positive serum beta-hCG]
Secondary Outcome(s)
Chemical pregnancy rate [Time Frame: 2 weeks after embryo transfer]
Implantation rate [Time Frame: 2 weeks after positive serum beta-hCG]
Secondary ID(s)
Si701/2015
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history